Sofat Diagnostics And Cancer Detection Centre Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.40 M
- Company Age 29 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 M
About Sofat Diagnostics And Cancer Detection Centre
Sofat Diagnostics And Cancer Detection Centre Pvt Ltd (SDACDCPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 November 1995 and has a history of 29 years and three months. Its registered office is in Na, Punjab.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹1.50 M.
Sumeet Sofat and Sumita Sofat serve as directors at the Company.
Company Details
- Location Na, Punjab
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85110PB1995PTC017234
-
Company No.
017234
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Nov 1995
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Sofat Diagnostics And Cancer Detection Centre?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumeet Sofat
|
Director | 04-Nov-1995 | Current |
|
Sumita Sofat
|
Director | 04-Nov-1995 | Current |
Financial Performance of Sofat Diagnostics And Cancer Detection Centre.
Sofat Diagnostics And Cancer Detection Centre Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sofat Diagnostics And Cancer Detection Centre?
In 2017, Sofat Diagnostics And Cancer Detection Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.50 M
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Feb 1996 | Punjab National Bank | ₹1.50 M | Open |
How Many Employees Work at Sofat Diagnostics And Cancer Detection Centre?
Sofat Diagnostics And Cancer Detection Centre has a workforce of 1 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sofat Diagnostics And Cancer Detection Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sofat Diagnostics And Cancer Detection Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.